4.7 Article

Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 64, 期 1, 页码 298-325

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.0c01704

关键词

-

资金

  1. National Natural Science Foundation of China [81773571, 81973173]
  2. Jiangsu Province Funds for Excellent Young Scientists [BK20170088]
  3. Fundamental Research Funds for the Central Universities [2632019ZD14]

向作者/读者索取更多资源

The study focuses on the role of reactive oxygen species in various diseases and the development of drugs for the targeted treatment and precise diagnosis of ROS-related diseases, also discussed are the activation mechanisms of ROS-responsive prodrugs.
Elevated levels of reactive oxygen species (ROS) have commonly been implicated in a variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In light of significant differences in ROS levels between the nonpathogenic and pathological tissues, an increasing number of ROS-responsive prodrugs, probes, and theranostic prodrugs have been developed for the targeted treatment and precise diagnosis of ROS-related diseases. This review will summarize and provide insight into recent advances in ROS-responsive prodrugs, fluorescent probes, and theranostic prodrugs, with applications to different ROS-related diseases and various subcellular organelle-targetable and disease-targetable features. The ROS-responsive moieties, the self-immolative linkers, and the typical activation mechanism for the ROS-responsive release are also summarized and discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据